| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Dr. Jemal is Strategic Director, Cancer Surveillance, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Siegel is Manager, Surveillance Information Services, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Ward is Managing Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Hao is Senior Epidemiologist, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Xu is Epidemiologist, Mortality Statistics Branch, Division of Vital Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD.
Mr. Murray is Manager, Surveillance Data Systems, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Thun is Vice President, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Published online through CA First Look at http://CAonline.AmCancerSoc.org.
Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. Incidence and death rates are age-standardized to the 2000 US standard million population. A total of 1,437,180 new cancer cases and 565,650 deaths from cancer are projected to occur in the United States in 2008. Notable trends in cancer incidence and mortality include stabilization of incidence rates for all cancer sites combined in men from 1995 through 2004 and in women from 1999 through 2004 and a continued decrease in the cancer death rate since 1990 in men and since 1991 in women. Overall cancer death rates in 2004 compared with 1990 in men and 1991 in women decreased by 18.4% and 10.5%, respectively, resulting in the avoidance of over a half million deaths from cancer during this time interval. This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, education, geographic area, and calendar year, as well as the proportionate contribution of selected sites to the overall trends. Although much progress has been made in reducing mortality rates, stabilizing incidence rates, and improving survival, cancer still accounts for more deaths than heart disease in persons under age 85 years. Further progress can be accelerated by supporting new discoveries and by applying existing cancer control knowledge across all segments of the population.
This article has been cited by other articles:
|
|
 |
|
  N. J. Meyer and J. D. Christie Extracellular Superoxide Dismutase Haplotypes and Acute Lung Injury: Reading into the Genome to Understand Mortality? Am. J. Respir. Crit. Care Med., January 15, 2009; 179(2): 89 - 91. [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Lippman, E. A. Klein, P. J. Goodman, M. S. Lucia, I. M. Thompson, L. G. Ford, H. L. Parnes, L. M. Minasian, J. M. Gaziano, J. A. Hartline, et al. Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) JAMA, January 7, 2009; 301(1): 39 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Karan, J. Holzbeierlein, and J. B. Thrasher Macrophage Inhibitory Cytokine-1: Possible Bridge Molecule of Inflammation and Prostate Cancer Cancer Res., January 1, 2009; 69(1): 2 - 5. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Czerninski, P. Amornphimoltham, V. Patel, A. A. Molinolo, and J. S. Gutkind Targeting Mammalian Target of Rapamycin by Rapamycin Prevents Tumor Progression in an Oral-Specific Chemical Carcinogenesis Model Cancer Prevention Research, January 1, 2009; 2(1): 27 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Mentor-Marcel, G. Bobe, K. G. Barrett, M. R. Young, P. S. Albert, M. R. Bennink, E. Lanza, and N. H. Colburn Inflammation-Associated Serum and Colon Markers as Indicators of Dietary Attenuation of Colon Carcinogenesis in ob/ob Mice Cancer Prevention Research, January 1, 2009; 2(1): 60 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yin, J. Ni, M. Chen, Y. Guo, and S. Yeh RRR-{alpha}-Vitamin E Succinate Potentiates the Antitumor Effect of Calcitriol in Prostate Cancer without Overt Side Effects Clin. Cancer Res., January 1, 2009; 15(1): 190 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Oliveria, J. M. Satagopan, A. C. Geller, S. W. Dusza, M. A. Weinstock, M. Berwick, M. Bishop, M. K. Heneghan, and A. C. Halpern Study of Nevi in Children (SONIC): Baseline Findings and Predictors of Nevus Count Am. J. Epidemiol., January 1, 2009; 169(1): 41 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Rychahou, J. Kang, P. Gulhati, H. Q. Doan, L. A. Chen, S.-Y. Xiao, D. H. Chung, and B. M. Evers Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis PNAS, December 23, 2008; 105(51): 20315 - 20320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Westin, R. A. Lacour, D. L. Urbauer, R. Luthra, D. C. Bodurka, K. H. Lu, and R. R. Broaddus Carcinoma of the Lower Uterine Segment: A Newly Described Association With Lynch Syndrome J. Clin. Oncol., December 20, 2008; 26(36): 5965 - 5971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Botteri, S. Iodice, V. Bagnardi, S. Raimondi, A. B. Lowenfels, and P. Maisonneuve Smoking and Colorectal Cancer: A Meta-analysis JAMA, December 17, 2008; 300(23): 2765 - 2778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Balan, P. Nangia-Makker, A. G. Schwartz, Y. S. Jung, L. Tait, V. Hogan, T. Raz, Y. Wang, Z. Q. Yang, G. S. Wu, et al. Racial Disparity in Breast Cancer and Functional Germ Line Mutation in Galectin-3 (rs4644): A Pilot Study Cancer Res., December 15, 2008; 68(24): 10045 - 10050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Dallas, M. J. Gray, L. Xia, F. Fan, G. van Buren II, P. Gaur, S. Samuel, S. J. Lim, T. Arumugam, V. Ramachandran, et al. Neuropilin-2-Mediated Tumor Growth and Angiogenesis in Pancreatic Adenocarcinoma Clin. Cancer Res., December 15, 2008; 14(24): 8052 - 8060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Garman, C. R. Acharya, E. Edelman, M. Grade, J. Gaedcke, S. Sud, W. Barry, A. M. Diehl, D. Provenzale, G. S. Ginsburg, et al. A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities PNAS, December 9, 2008; 105(49): 19432 - 19437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jemal, M. J. Thun, L. A. G. Ries, H. L. Howe, H. K. Weir, M. M. Center, E. Ward, X.-C. Wu, C. Eheman, R. Anderson, et al. Annual Report to the Nation on the Status of Cancer, 1975-2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control J Natl Cancer Inst, December 3, 2008; 100(23): 1672 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Panici, S. Basile, F. Maneschi, A. A. Lissoni, M. Signorelli, G. Scambia, R. Angioli, S. Tateo, G. Mangili, D. Katsaros, et al. Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial J Natl Cancer Inst, December 3, 2008; 100(23): 1707 - 1716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Brune, S.-M. Hong, A. Li, S. Yachida, T. Abe, M. Griffith, D. Yang, N. Omura, J. Eshleman, M. Canto, et al. Genetic and Epigenetic Alterations of Familial Pancreatic Cancers Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3536 - 3542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, S. K. McDonnell, S. J. Hebbring, J. M. Cunningham, J. St Sauver, J. R. Cerhan, G. Isaya, D. J. Schaid, and S. N. Thibodeau Polymorphisms in Mitochondrial Genes and Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3558 - 3566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Demark-Wahnefried, T. J. Polascik, S. L. George, B. R. Switzer, J. F. Madden, M. T. Ruffin IV, D. C. Snyder, K. Owzar, V. Hars, D. M. Albala, et al. Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3577 - 3587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. McFall and M. Davila Gender, Social Ties, and Cancer Screening Among Elderly Persons J Aging Health, December 1, 2008; 20(8): 997 - 1011. [Abstract] [PDF]
|
|
|
|
|
|
F. Kassie, I. Matise, M. Negia, P. Upadhyaya, and S. S. Hecht Dose-Dependent Inhibition of Tobacco Smoke Carcinogen-Induced Lung Tumorigenesis in A/J Mice by Indole-3-Carbinol Cancer Prevention Research, December 1, 2008; 1(7): 568 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Paulson, J. Ra, K. Armstrong, C. Wirtalla, F. Spitz, and R. R. Kelz Underuse of Esophagectomy as Treatment for Resectable Esophageal Cancer Arch Surg, December 1, 2008; 143(12): 1198 - 1203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Inamoto, S. Papineni, S. Chintharlapalli, S.-D. Cho, S. Safe, and A. M. Kamat 1,1-Bis(3'-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth Mol. Cancer Ther., December 1, 2008; 7(12): 3825 - 3833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Neupane and M. Korc 14-3-3{sigma} Modulates Pancreatic Cancer Cell Survival and Invasiveness Clin. Cancer Res., December 1, 2008; 14(23): 7614 - 7623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Walsh, S. Ogawa, D. R. Scoles, C. W. Miller, N. Kawamata, S. A. Narod, H. P. Koeffler, and B. Y. Karlan Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA1/2-Associated Ovarian Carcinomas Clin. Cancer Res., December 1, 2008; 14(23): 7645 - 7651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lurje, F. Nagashima, W. Zhang, D. Yang, H. M. Chang, M. A. Gordon, A. El-Khoueiry, H. Husain, P. M. Wilson, R. D. Ladner, et al. Polymorphisms in Cyclooxygenase-2 and Epidermal Growth Factor Receptor Are Associated with Progression-Free Survival Independent of K-ras in Metastatic Colorectal Cancer Patients Treated with Single-Agent Cetuximab Clin. Cancer Res., December 1, 2008; 14(23): 7884 - 7895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Horikawa, C. G. Wood, H. Yang, H. Zhao, Y. Ye, J. Gu, J. Lin, T. Habuchi, and X. Wu Single Nucleotide Polymorphisms of microRNA Machinery Genes Modify the Risk of Renal Cell Carcinoma Clin. Cancer Res., December 1, 2008; 14(23): 7956 - 7962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wang, M. A. Dimopoulos, C. Chen, M. T. Cibeira, M. Attal, A. Spencer, S. V. Rajkumar, Z. Yu, M. Olesnyckyj, J. B. Zeldis, et al. Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure Blood, December 1, 2008; 112(12): 4445 - 4451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. U. Ahmed, R. L. Schmidt, C. H. Park, N. R. Reed, S. E. Hesse, C. F. Thomas, J. R. Molina, C. Deschamps, P. Yang, M. C. Aubry, et al. Effect of Disrupting Seven-in-Absentia Homolog 2 Function on Lung Cancer Cell Growth J Natl Cancer Inst, November 19, 2008; 100(22): 1606 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Gill, M. F. Vazquez, A. Kramer, M. Hames, L. Zhang, K. Heselmeyer-Haddad, T. Ried, K. Shilo, C. Henschke, D. Yankelevitz, et al. The Use of Genetic Markers to Identify Lung Cancer in Fine Needle Aspiration Samples Clin. Cancer Res., November 15, 2008; 14(22): 7481 - 7487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Schultheis, G. Lurje, K. E. Rhodes, W. Zhang, D. Yang, A. A. Garcia, R. Morgan, D. Gandara, S. Scudder, A. Oza, et al. Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab Clin. Cancer Res., November 15, 2008; 14(22): 7554 - 7563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dhar, F. X. Gu, R. Langer, O. C. Farokhzad, and S. J. Lippard Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles PNAS, November 11, 2008; 105(45): 17356 - 17361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tripathi, S. Nandana, H. Yamashita, R. Ganesan, D. Kirchhofer, and V. Quaranta Laminin-332 Is a Substrate for Hepsin, a Protease Associated with Prostate Cancer Progression J. Biol. Chem., November 7, 2008; 283(45): 30576 - 30584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Weinstein, D. Albanes, J. Selhub, B. Graubard, U. Lim, P. R. Taylor, J. Virtamo, and R. Stolzenberg-Solomon One-Carbon Metabolism Biomarkers and Risk of Colon and Rectal Cancers Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3233 - 3240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. E. Miller Minimizing Unintended Consequences of Detecting Lung Nodules by Computed Tomography Am. J. Respir. Crit. Care Med., November 1, 2008; 178(9): 891 - 892. [Full Text] [PDF]
|
|
|
|
 |
|
 N. F. Esnaola, A. K. Stewart, B. W. Feig, J. M. Skibber, and M. A. Rodriguez-Bigas Age-, Race-, and Ethnicity-Related Differences in the Treatment of Nonmetastatic Rectal Cancer: A Patterns of Care Study From the National Cancer Data Base Ann. Surg. Oncol., November 1, 2008; 15(11): 3036 - 3047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Riggins, J. P-J. Lan, U. Klimach, A. Zwart, L. R. Cavalli, B. R. Haddad, L. Chen, T. Gong, J. Xuan, S. P. Ethier, et al. ERR{gamma} Mediates Tamoxifen Resistance in Novel Models of Invasive Lobular Breast Cancer Cancer Res., November 1, 2008; 68(21): 8908 - 8917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Yao, A. Parwani, C. Maier, W. D. Heston, and D. J. Bacich Moderate Expression of Prostate-Specific Membrane Antigen, a Tissue Differentiation Antigen and Folate Hydrolase, Facilitates Prostate Carcinogenesis Cancer Res., November 1, 2008; 68(21): 9070 - 9077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Warrenfeltz, S. A. Lott, T. M. Palmer, J. C. Gray, and D. Puett Luteinizing Hormone-Induced Up-Regulation of ErbB-2 Is Insufficient Stimulant of Growth and Invasion in Ovarian Cancer Cells Mol. Cancer Res., November 1, 2008; 6(11): 1775 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. O. Wilson, J. L. Weissfeld, C. R. Fuhrman, S. N. Fisher, P. Balogh, R. J. Landreneau, J. D. Luketich, and J. M. Siegfried The Pittsburgh Lung Screening Study (PLuSS): Outcomes within 3 Years of a First Computed Tomography Scan Am. J. Respir. Crit. Care Med., November 1, 2008; 178(9): 956 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Yang, Z. Sun, D. Chan, C. A. Cartwright, M. Vijjeswarapu, J. Ding, X. Chen, and R. A. Newman Zyflamend(R) reduces LTB4 formation and prevents oral carcinogenesis in a 7,12-dimethylbenz[{alpha}]anthracene (DMBA)-induced hamster cheek pouch model Carcinogenesis, November 1, 2008; 29(11): 2182 - 2189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Chen, E. M. Sturgis, A. K. El-Naggar, Q. Wei, and G. Li Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers Carcinogenesis, November 1, 2008; 29(11): 2120 - 2125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Smith, E. A. Levine, R. I. Freimanis, S. A. Akman, G. O. Allen, K. N. Hoang, W. Liu-Mares, and J. J. Hu Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk Carcinogenesis, November 1, 2008; 29(11): 2132 - 2138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lin, X. Pu, W. Wang, S. Matin, N. M. Tannir, C. G. Wood, and X. Wu Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma Carcinogenesis, November 1, 2008; 29(11): 2112 - 2119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Iagaru, S. S. Gambhir, and M. L. Goris 90Y-Ibritumomab Therapy in Refractory Non-Hodgkin's Lymphoma: Observations from 111In-Ibritumomab Pretreatment Imaging J. Nucl. Med., November 1, 2008; 49(11): 1809 - 1812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Costa, K.-S. H. Nguyen, B. C. Cho, L. V. Sequist, D. M. Jackman, G. J. Riely, B. Y. Yeap, B. Halmos, J. H. Kim, P. A. Janne, et al. Effects of Erlotinib in EGFR Mutated Non-Small Cell Lung Cancers with Resistance to Gefitinib Clin. Cancer Res., November 1, 2008; 14(21): 7060 - 7067. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Berhoune, E. Banu, F. Scotte, P. Prognon, S. Oudard, and B. Bonan Therapeutic Strategy for Treatment of Metastatic Non-Small Cell Lung Cancer Ann. Pharmacother., November 1, 2008; 42(11): 1640 - 1652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Landier and S. Bhatia Cancer Survivorship: A Pediatric Perspective Oncologist, November 1, 2008; 13(11): 1181 - 1192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Messersmith and D. J. Ahnen Targeting EGFR in Colorectal Cancer N. Engl. J. Med., October 23, 2008; 359(17): 1834 - 1836. [Full Text] [PDF]
|
|
|
|
|
|
B. B. Hafeez, I. A. Siddiqui, M. Asim, A. Malik, F. Afaq, V. M. Adhami, M. Saleem, M. Din, and H. Mukhtar A Dietary Anthocyanidin Delphinidin Induces Apoptosis of Human Prostate Cancer PC3 Cells In vitro and In vivo: Involvement of Nuclear Factor-{kappa}B Signaling Cancer Res., October 15, 2008; 68(20): 8564 - 8572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Brinton, D. A. Richesson, G. L. Gierach, J. V. Lacey Jr, Y. Park, A. R. Hollenbeck, and A. Schatzkin Prospective Evaluation of Risk Factors for Male Breast Cancer J Natl Cancer Inst, October 15, 2008; 100(20): 1477 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E.W. Cohen, L. S. Rosen, E. E. Vokes, M. S. Kies, A. A. Forastiere, F. P. Worden, M. A. Kane, E. Sherman, S. Kim, P. Bycott, et al. Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study J. Clin. Oncol., October 10, 2008; 26(29): 4708 - 4713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yano, S. Tsutsumi, S. Soga, M.-J. Lee, J. Trepel, H. Osada, and L. Neckers Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone PNAS, October 7, 2008; 105(40): 15541 - 15546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. McCarthy Melanoma of the scalp and neck had greater risk of melanoma-specific mortality than melanoma of the extremities Evid. Based Med., October 1, 2008; 13(5): 155 - 155. [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Kight Nutrition Considerations in Esophagectomy Patients Nutr Clin Pract, October 1, 2008; 23(5): 521 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Bao and D. S. Michaud Physical Activity and Pancreatic Cancer Risk: A Systematic Review Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2671 - 2682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Brait, S. Begum, A. L. Carvalho, S. Dasgupta, A. L. Vettore, B. Czerniak, O. L. Caballero, W. H. Westra, D. Sidransky, and M. O. Hoque Aberrant Promoter Methylation of Multiple Genes during Pathogenesis of Bladder Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2786 - 2794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
